JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 12 March 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.01587-07v1
82/10/4793    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Rappocciolo, G.
Right arrow Articles by Rinaldo, C. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rappocciolo, G.
Right arrow Articles by Rinaldo, C. R.
J. Virol. doi:10.1128/JVI.01587-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

HHV-8 INFECTS AND REPLICATES IN PRIMARY CULTURES OF ACTIVATED B LYMPHOCYTES THROUGH DC-SIGN

Giovanna Rappocciolo*, Heather H. Hensler, Mariel Jais, Todd A. Reinhart, Amarendra Pegu, Frank J. Jenkins, and Charles R. Rinaldo

Department of Infectious Diseases and Microbiology, Graduate School of Public Health; and Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261

* To whom correspondence should be addressed. Email: giovanna{at}pitt.edu.


   Abstract

Human herpesvirus 8 (HHV-8) is the etiological agent of Kaposi's sarcoma (KS), primary effusion lymphoma and some forms of multicentric Castleman's disease . Although latent HHV-8 DNA can be detected in B cells in persons with these cancers, there is little information on replication of HHV-8 in B cells. Indeed, B cells are relatively resistant to HHV-8 infection in vitro. We have recently shown that DC-SIGN, a C-type lectin first identified on dendritic cells (DC), is an entry receptor for HHV-8 on DC and macrophages. We have also demonstrated that B lymphocytes from peripheral blood and tonsils express DC-SIGN, and this expression increases after B cell activation. Here we show that activated blood and tonsillar B cells can be productively infected with HHV-8 as measured by an increase in viral DNA, the expression of viral lytic and latency proteins and the production of infectious virus. Infection of B cells by HHV-8 was blocked by pretreatment of the cells with antibody specific for DC-SIGN or mannan but not by antibody specific for xCT, a cystine/glutamate exchange transporter that has been implicated in HHV-8 fusion to cells. Infection of B cells with HHV-8 resulted in increased expression of DC-SIGN and a decrease in expression of CD20 and MHC class I. HHV-8 could also infect and replicate in B cell lines transduced to express full length DC-SIGN but not in B cell lines transduced with DC-SIGN lacking the transmembrane domain, demonstrating that entry of HHV-8 into B cells is related to DC-SIGN-mediated endocytosis. The role of endocytosis in viral entry was confirmed in activated B cells by blocking HHV-8 infection with endocytic pathway inhibitors Thus, expression of DC-SIGN is essential for productive HHV-8 infection and replication in B cells.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.